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Most of the iron in the plasma is bound to transferrin (Tf) and is taken up by cells through their surface Tf receptors (TfRs).
Under pathological conditions of iron-overload, the plasma iron which is in excess of the binding capacity of Tf is present as
non-Tf-bound iron. We probed the uptake of non-Tf iron and its consequences on the oxidative status of peripheral RBC and
reticulocytes as well as developing erythroid precursors grown in vitro. The cells were exposed to ferrous ammoniumsulfate under
Tf-supplemented and Tf-free conditions.Using ﬂow cytometry techniques, we found thatboth the TfR-deﬁcient mature RBC and
their TfR-containing precursors at all stages of maturation can take up non-Tf iron that accumulates as redox-active labile iron
and generates reactive oxygen species. Such a mechanism may account for ineﬀective erythropoiesis of developing precursors in
the bone marrow and for the shortening of the lifespan of mature RBCs in the circulation.
1.Introduction
Most of the iron in the plasma is bound to transferrin
(Tf) which serves as a carrier protein that mediates the
uptake of iron by cells through their surface Tf receptor-1
(TfR)[1]. Intracellularly, iron is released from Tf following a
decrease in endosomal pH and is thentransported across the
endosomal membrane by DMT1 (also known as Nramp2)
[2]. Under pathological conditions of iron-overload, plasma
iron which is in excess of the binding capacity of Tf is present
asnon-Tf boundiron(NTBI)[3].Thischemicallyill-deﬁned
iron and its redox potent labile plasma iron (LPI) can be
taken up by cells in vital organs via several pathways and be
responsible for the major pathological consequencesof iron-
overload [4].
In erythroid cells, while most of the iron is in the form
of hemoglobin (Hb), some iron is in the form of labile
iron [5]. It has a redox potential and generates reactive
oxygen species (ROS) which leads to cytotoxic eﬀects [6].
We have previously reported that the labile iron pool (LIP),
also termed labile cellular iron (LCI), is increased in RBCs
under conditions of iron overload, such as in the case of
chronic anemias associated with blood transfusions [7].
Increased LIP in RBCs may be the result of abnormal
iron turnover in developing precursors (due to increased
uptake from iron-overloaded plasma, diminished utilization
because of reduced Hb production, or degradation of
unstable Hb). In addition, RBCs may take up NTBI from
their environment (the plasma). Iron uptake by RBCs and
reticulocytes (retics) has been previously demonstrated in
various model systems using radiolabeled iron [8–11]. But,
the results have been disputed because the experiments were
carried out in artiﬁcial media containing high sucrose. In
the present study, we probed the uptake of non-Tf iron by
various erythroid cells. We utilized a novel ﬂow cytometry
methodology [12] to measure the uptake of iron and the
generation of ROS by peripheral blood RBCs and retics in
their autologous plasma as well as by human developing
erythroid precursors grown in vitro. The results showed that
both the TfR-deﬁcient mature RBCs and the TfR-bearing
erythroid precursors at all stages of maturation can take up
non-Tf iron. This uptake was associated with increased LIP
and ROS generation. Such a mechanism may account for the
hematological consequences of iron-overload—ineﬀective
erythropoiesis and short lifespan of RBCs in the circulation.
2.Methods
2.1. Blood Cells and Erythroid Cultures. Normal human
peripheralRBCs,obtainedinheparin-containing tubes,were2 Anemia
used in all experiments, unless otherwise stated. Some
experiments were performed with RBCs obtained from
thalassemic mice. The founders of the mouse colony were
obtainedfromDr.S.Rivella,WeillMedicalCollegeofCornell
University, NY, NY. Heterozygotes (Hbb
th3/+) mice exhibit
severeanemia(7to9g/dLHb),abnormalRBCsmorphology,
splenomegaly, and hepatic iron deposition [13]. Animals
were bred at the animal facility of Hadassah—Hebrew
University Medical Center. The research was approved by
the Hadassah—Hebrew University Medical Center Human
Experimentation Review Board and the Animal Ethics
Committee. All human participants gave written informed
consent.
Erythroid cultures were initiated by growing human
peripheral blood mononuclear cells in a two-phase liquid
culture system as previously described in [14, 15]. In short,
cells were ﬁrst cultured in alpha medium supplemented
with 10% fetal calf serum and 10% conditioned medium
obtained from cultures of the human 5637 bladder car-
cinoma cell line and 1μg/mL cyclosporin A (phase I).
After 7 days, nonadherent cells were harvested, washed and
suspended in phase II medium, containing alpha medium,
30% fetal calf serum, 1% bovine serum albumin, 10μM β-
mercaptoethanol,1.5mMglutamine,10μMdexamethasone,
5ng/ml stem cell factor and 1U/ml human recombinant
erythropoietin. Hb-containing cells were scored by staining
with benzidine dihydrochloride [15].
2.2. Iron and Chelators. Ferrous ammonium sulfate (FAS)
(Sigma, St. Louis, MO) was freshly dissolved for each
experiment in water to 1mM. Human holotransferrin (90%
saturated) was purchased from Biological Industries (Beit-
Hemek, Israel) and added to cells at 300μg/mL. Deferiprone
(L1) (Apotex, Weston, ON, Canada) was freshly dissolved in
water to 20mM and added at 50μM.
2.3. Measurements of Iron Uptake and ROS Generation.
Iron uptake was measured as previously described in [12].
For measurement of cytoplasmic LIP cells were loaded
for 15min at 37◦C with calcein acetoxymethyl ester (CA-
AM) (Sigma-Aldrich, St. Louis, MO) (1μMf o rR B C s
and retics, and 0.5μM for cultured cells). CA-AM enters
viable cells and becomes ﬂuorescent upon hydrolysis by
esterases; its ﬂuorescence is quenched by binding of LIP [16–
19]. Mitochondrial LIP was measured by staining cultured
cells with 1μM rhodamine B-[(1,10-phenanthrolin-5-yl)-
aminocarbonyl] benzyl ester (RPA, Squarix biotechnology,
Marl, Germany) for 20min at 37◦C as previously described
in [12].
ROS were measured by staining with 0.1mM 2 –7 -
dichloroﬂuorescin diacetate (DCF, Sigma) for 15min at
37◦C[ 20]. Upon crossing the membrane, this compound
undergoesdeacetylationby intracellular esterases, producing
a nonﬂuorescent compound that is trapped inside the
cells. Its oxidation by ROS produced a highly ﬂuorescent
compound—2 –7 -dichloroﬂuorescine (CA) [21].
2.4.FlowCytometry. Cellﬂuorescencewasanalyzedbyaﬂow
cytometer (FACS-calibur
R, Becton-Dickinson, Immunoﬂu-
orometry systems, Mountain View, CA) as previously
described in [12]. A 488-nm argon and 635-nm red diode
lasers were used for excitation. At least 20,000 cells were
analyzed using logarithmic ampliﬁcation for the ﬂuores-
cence signal height and linear ampliﬁcation for forward
light scatter and side light scatter. “Threshold” was set on
forward light scatter to exclude cell debris, microparticles
and platelets. In some experiments, blood cells were stained
simultaneously with CA or DCF and an allophycocyanin-
(APC-) conjugated anti-CD71 antibody (Becton-Dickinson,
San Jose, CA) for 15min at 37◦C. Cells were gated as
CD71+ (retics) and CD71− (RBCs), and the green ﬂuo-
rescence (CA or DCF) of each population was measured.
Mitochondrial LIP was measured in cultured erythroid
cells stained with RPA. The arithmetic Mean Fluorescence
Intensities (MFI) were calculated by the CellQuest
R software
(Becton-Dickinson). For each experiment, unstained cells
served as controls; their MFI was <10. The statistical
signiﬁcance was calculated using the two-sample Student’s
t-test for diﬀerences in means P<. 05 was considered
signiﬁcant.
3.Results
The ﬂow cytometry methodology for measuring iron uptake
and ROS generation in RBCs and retics is illustrated in
Figure 1. Blood cells were diluted in PBS, labeled with
an APC-conjugated anti-CD71 antibody and either CA-
AM or DCF, washed with PBS, diluted in their autologous
plasma, and incubated with or without FAS (20μMf o r1h r ) .
Figures 1(a) and 1(b) demonstrate FSC × CD71 dot plots of
RBCs(CD71−)a n dr e t i c s( C D 7 1 +), respectively. Figures 1(c)
and 1(d) show histogram distributions of both populations
with respect to CA- and DCF-ﬂuorescence, respectively.
Cells incubated without iron showed a much higher basal
CA-ﬂuorescence (MFI−Fe 1450 versus 810) and DCF-
ﬂuorescence (1003 versus 315) in retics compared to RBCs
(Figures 1(e) and 1(f)). Iron uptake resulted in a decrease
in the CA-ﬂuorescence (Figure 1(e)) and an increase in the
DCF-ﬂuorescence (Figure 1(f)). The data for each popula-
tion were reported as the percent change in the MFI follow-
ingincubationwithFAS,calculatedas percentageofthebasal
ﬂuorescence [100 × (MFI − Fe – MFI + Fe)/(MFI − Fe)]. In
the representative experiment shown in Figure 1,t h ec h a n g e
in the CA-MFI was 14.9% for RBCs and 20.7% for retics
(Figure 1(e)). The change in the DCF-MFI was 34.9% for
RBCs and 35.2% for retics (Figure 1(f)).
Using this methodology, we studied the time- and dose-
related eﬀects (Figures 2(a) and 2(b), resp.) of iron uptake
by RBCs and retics. Iron uptake was detected as early as
1min after addition of FAS. It was faster in retics than in
RBCs; in RBCs it plateaued after 45min, whereas in retics
it continued to increase for 3hrs, reaching 6.8-fold higher
levelsthaninRBCs.InbothRBCsandretics, ironuptakewas
dose dependent; it was detected at 1μM FAS and increased
up to 20μM. Iron uptake was associated with increased ROSAnemia 3
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Figure 1: Flow cytometry measurement of iron uptake and reactive oxygen species (ROS) generation in RBCs and reticulocytes. Normal
peripheral blood cells were diluted (5×106/ml)inPBS,stainedwithCA-AM orDCFandanAPC-conjugated anti-CD71antibody. Following
washingwith PBS,they were resuspended in their autologousplasmaandthen incubated with (+Fe) or without (−Fe) 20μMF e SO 4 for 1hr.
(a) A FSC ×CD71 dot-plot, showing the gates for RBCs (CD71−) and reticulocytes (retics) (CD71+). (b) A FSC ×CD71 dot-plot of events
acquired in the retic gate. (c, d) Histogram distributions of both populations with respect to CA- and DCF-ﬂuorescence, respectively. (e, f)
Summaries of the results obtained in each population following incubation with and without Fe. The MFIs and the percent change in the
MFIs of each population incubated with and without Fe, calculated per the basal ﬂuorescence (MFI−Fe) are indicated.
generation during the ﬁrst 15–30min in both RBCs and in
retics (Figures 2(c) and 2(d)).
Normal plasma contains unsaturated Tf, therefore some
of the iron added in these experiments became bound to Tf.
Since mature RBCs are devoid of TfR [22], their iron uptake
is necessarily Tf independent. To substantiate this point and
to determine whether such a mechanism is operative also in
retics, iron uptake was measured in parallel in Tf-containing
(autologous plasma) and Tf-free media. The results showed
that iron uptake was slower in plasma (2.5-fold in RBCs and4 Anemia
60 0 1 02 03 04 05 0
Iron uptake
C
h
a
n
g
e
(
%
)
0
5
10
15
20
25
30
35
Time(min)
Retics
RBCs
(a)
Iron uptake
C
h
a
n
g
e
(
%
)
0 51 0 1 5 2 0 25 30 35
0
10
20
30
40
50
FAS conc.(μM)
(b)
0 20 40 60 80 100 120
C
h
a
n
g
e
(
%
)
0
5
10
15
20
25
30
35
ROS
Time(min)
(c)
0
10
20
30
40
50
60
70
80
90
60 0 1 02 03 04 05 0
ROS
C
h
a
n
g
e
(
%
)
FAS conc. (μM)
(d)
Figure 2: Time- and dose-related iron uptake and ROS generation by RBCs and reticulocytes. Normal peripheral blood cells were labeled,
suspended intheir autologousplasmaand incubated withor withoutFeSO4 (FAS) as described in the legends to Figure 1.(a,c) Labeled cells
were incubated with orwithout20μM FAS forthe indicated durations.(b,d) Labeled cells were incubated with theindicated concentrations
of FAS for 1hr. The results of iron uptake (a, b) and ROS generation (c, d) in RBCs (◦)a n dr e t i c s(
￿) are expressed as the percent (%)
change (mean ±SD, N = 4) in the MFIs followingincubation with and without Fe, calculated per the MFI−Fe.
2-fold in retics, both P<. 01) and indicated that both cells
take up iron by a Tf-independent mechanism.
In order to probe the nature of the incoming iron, CA-
loadedRBCswereexposedto20μMF ASinPBS,washed,and
then further incubated with or without the cell-permeable
iron-chelator-L1 (50μM for 1hr). The results showed a 33%
(P = .005)increaseintheCA-MFIfollowingincubationwith
L1, similar to the ﬂuorescence of iron-untreated cells. The
ability of L1 to overcome the iron-mediated quenching of
CA, most probably by binding and thus removing iron from
its complex with CA, fulﬁls the operational deﬁnition of the
incoming iron as LIP [12].
To establish the pathological signiﬁcance of non-Tf
iron uptake, we used blood from heterozygotes (Hbb
th3/+)
mice, a mouse model of β-thalassemia, which suﬀer from
iron-overload [13]. CA-loaded normal mouse RBCs were
incubated for 1 hour in plasma derived either from normal
or thalassemic mice. The results showed lower CA-MFI of
RBCsincubatedinthalassemic plasmaby10±2%(P = .005),
indicating increased LIP than the same RBCs incubated in
normal plasma. These results suggest that in thalassemia,
continuous, Tf-independent, uptake of iron from the plasma
might have a signiﬁcant eﬀe c to nt h eR B C sL I Pc o n t e n t .
To determine the ability of developing erythroid precur-
sors to take up iron in a Tf-independent pathway, cultured
erythroid precursors were harvested on days 7-8 of phase
II cultures, loaded with CA, washed, and resuspended in
phase II medium (containing 30% serum) or in PBS and
incubated for 1 or 2hrs with diﬀerent concentrationsof FAS.
The results (Figure 3(a)) indicated enhanced iron uptakeAnemia 5
in PBS than in serum-containing medium (P = .001).
Tf-independent iron uptake in PBS was associated with
increased ROS generation as reﬂected by DCF ﬂuorescence
(Figure 3(b)). In another set of experiments, the CA-loaded
cells were washed, and resuspended in PBS supplemented
with or without Tf (300μg/mL) and incubated for 1–3hrs
with diﬀerent concentrations of FAS (Figure 3(c)). The
results showed that in the presence of Tf, iron uptake was
slower, but after 3hrs, at the higher concentrations of FAS
(20–50μM),theintracellularironreachedacomparablelevel
to that of cells incubated without Tf.
When erythroid precursors from day 6 phase II cultures
were washed and incubated in PBS with 20μMF A Sf o r1h r ,
theydemonstratednotonlyanincreasedcytoplasmicLIPbut
also a signiﬁcant increase (P = .001) in mitochondrial LIP,
assayed bythechange in theﬂuorescenceofa mitochondrial-
speciﬁc probe (RPA), and in ROS (Figure 4(a)).
The eﬀect of non-Tf iron on development of erythroid
cells was demonstrated by adding various concentrations
of FAS to day 6 phase II cultures. Counting Hb-containing
cells after 3 days indicated a signiﬁcant decrease (FAS =
100μMv e r s u sF A S= 0, P<. 001) by the addition of iron
(Figure 4(b)).
4.Discussion
T h el a b i l ei r o np o o l( L I P )i sc o n s i d e r e dt h em a i nc a u s eo f
malfunctioning of vital organs (e.g., heart, liver, endocrine
glands) of patients with iron-overload [3, 23]. Increased
LIP may be deleterious to erythroid cells as well; it may
be involved in increased apoptosis of developing precursors
i nt h eb o n em a r r o w( i n e ﬀective erythropoiesis) [24]a n d
in shortening of the lifespan of mature RBCs due to
extravascular hemolysis. The cytotoxic eﬀects of LIP are
probably mediated by increased generation of ROS and the
resultant state of oxidative stress [25, 26]. In thalassemia,
where iron overload is caused by enhanced iron absorption
in the gastrointestinal track [27] and by frequent blood
transfusions, we have shown that LIP is high in RBCs
and retics, as well as in immature developing erythroid
precursors, compared to their normal counterparts [7].
Increased LIP in RBCs may be the result of leftover of
unused iron in precursors due to increased uptake (from
iron-overloaded plasma), diminished utilization because of
reduced Hb production, or degradation of unstable Hb. In
addition, RBCs may take up iron from their environment,
especially when the amount of iron in the plasma exceeds the
binding capacity of Tf. Since mature RBCs are devoid of TfR
[22], this uptake is necessarily of non-Tf iron.
In the present study we probed the uptake of non-Tf iron
supplied as FAS and its consequences on ROS generation in
normal human peripheral blood RBCs and retics as well as
in their precursors grown in vitro. The incoming iron and
the ROS generation were measured by ﬂow cytometry of
cellsloadedwith ﬂuorescentprobes,CAorDCF,respectively.
Iron uptake resulted in a decrease in CA-ﬂuorescence while
ROS generation resulted in an increase in DCF-ﬂuorescence.
The results were expressed as the percent change in the
MFI of iron-treated cells compared to untreated cells. Dual
staining with CA or DCF and APC-conjugated antibodies to
TfR (CD71) permitted simultaneous analysis of RBCs (TfR-
negative cells) and retics (TfR-bearing cells). The results
indicated that iron uptake by RBCs and retics was dose-
and time dependent. It was detected at FAS concentrations
as low as 1μM and increased at higher concentrations.
The uptake was faster and reached higher levels in retics
than in RBCs. The ability of the incoming iron to bind
and quench the ﬂuorescence of CA indicated its labile,
chelatable nature. Indeed, when the potent, cell permeable
iron-chelator, deferiprone (L1), was added to FAS-treated
cells it increased the CA-ﬂuorescence to levels of FAS-
untreated cells.
The results also showed that iron uptake by both cell
types was associated with an enhanced ROS generation,
which was ameliorated by L1. The latter results are in
agreementwithourpreviousreportthatinvitrotreatmentof
iron-overloaded thalassemic RBCs with clinically used iron-
chelators, including L1, decreased their LIP as well as ROS
[28].
In the present study, iron uptake was ﬁrst analyzed by
exposing peripheral blood cells to FAS in their autologous
plasma. Normal plasma, however, contains unsaturated Tf;
someoftheaddedironintheseexperimentscould,therefore,
bind to and delivered by Tf. Sincemature RBCsare devoidof
TfR [22], their iron uptake was necessarily Tf independent.
To study whether Tf-independent iron uptake was also
operative in TfR-carrying retics, we exposed the cells to FAS
in parallel in Tf-containing (autologous plasma) and in Tf-
free (PBS) media. The results showed slower iron uptake in
plasma than inPBS andindicatedthosebothRBCsandretics
take up iron by Tf-independent mechanisms. These results
areinagreementwithpreviousdatathatnormalmouseretics
acquire non-Tf iron at rates much higher than that at which
iron is taken up physiologically from Tf [29]. These results
and our present data suggest that in iron-overload, when
non-Tf iron ispresent in theserum, the levelsofTf-receptors
do not represent a limiting factor in iron uptake.
The uptake of non-Tf iron by rats and mouse RBCs and
reticshasbeenpreviouslystudiedinvitrousingradio-labeled
iron. Under the experimental conditions used (e.g., high
sucrose-containing medium), it was found that immature
erythroid cells acquire non-Tf iron, most probably through
their DMT1 transmembrane transport system. But, since
physiologically all iron in the circulation is Tf-bound, DMT1
expressed at the plasma membrane has no substrate; it was
assumed to function not as an external transporter but to
mobilize iron intracellularly, for example, iron transport
across the endosomal or the mitochondrial membranes [29].
The uptake of non-Tf iron by developing erythroid
cells was studied in cultures derived from normal human
erythroid progenitors. These cultures have been previously
demonstrated to recapitulate erythropoiesis in vivo, includ-
ing various aspects of iron metabolism [30]. Following
culture in serum-containing medium, the cells were har-
vested, washed, loaded with CA, and resuspended in PBS
or complete serum-containing culture medium. Iron entry
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Figure 3: The eﬀect of transferrin (Tf) on iron uptake and ROS by cultured erythroid precursors. Cultured human erythroid precursors
were harvested on days 7-8 of phase II, washed and loaded with CA or DCF. (a) CA-loaded cells were washed and resuspended in PBS or
in phase II medium (complete medium, containing 30% serum), and incubated for 1- or 2hrs with the indicated concentrations of FAS.
(b) DCF-loaded cells were washed and resuspended in PBS, and incubated for 1- or 2hrs with the indicated concentrations of FAS. (c)
CA-loaded cells were washedandresuspended in PBS supplemented with or without humanholo-Tf (300μg/mL)and incubated for1–3 hrs
with the indicated concentrations of FAS. The results indicated reduced iron uptake in the presence of Tf. The results are expressed as the
percent (%) change (mean ±SD, N = 4) in the MFIs following incubation with and without Fe, calculated per the MFI−Fe.
indicating that Tf-independent iron uptake is operative in
these cells too. We then studied the direct eﬀect of Tf. The
results indicated that iron uptake from Tf was much slower
than that from FAS. When holo-Tf (90% saturated) was
addedtogetherwithFAS,ironuptakewasretardedcompared
to FAS alone. It is interesting to note in this context that
treating thalassemic mice with apo-Tf has been shown to
reduce their iron load [31].
TheresultsindicatedthatRBCs,reticsaswellaserythroid
precursors at early stages of maturation take up iron
through a Tf-independent pathway. It is unlikely that this
pathway is operative normally, but only under pathological
iron-overload situation when NTBI appears in the serum.
Whether erythroid cellsat various stages ofmaturation share
thesamemechanism ofTf-independentironuptakeisstillan
open question. Although the incoming non-Tf iron is found
in the mitochondria of erythroid precursors, as determined
by reducing the RPA ﬂuorescence (Figure 4), it is not
likely to participate in heme synthesis and Hb production.
We have previously shown that, unlike Tf-iron and to
some extent iron-ferritin and hemin, non-Tf iron cannot
support the survival, proliferation, and hemoglobinizationAnemia 7
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Figure 4: The eﬀects of non-transferrin iron uptake on cytoplasmic and mitochondrial LIP and ROS generation by cultured erythroid
precursors. Cultured human erythroid precursors were harvested on day 6 of phase II, incubated with or without 20 μMF A Sf o r1h r ,a n d
stained with CA, RPA or DCF for measurement of cytoplasmic and mitochondrial LIPs and ROS generation, respectively. The results are
expressed as the percent (%) change (mean±SD, N = 4) in the MFIs followingincubation with andwithout Fe, calculated per the MFI−Fe.
(b) The indicated concentrations of FAS were added to day 6 cultures. Hb-containing cells were counted by benzidine staining on day 9. The
results are expressed as the (mean ±SD, N = 4).
of erythroid precursors in vitro [32]. In contrast, non-Tf
iron uptake involves in the induction of ROS generation
and its cytopathological consequences, as demonstrated by
a decrease in erythroid cell yield in cultures exposed to FAS
(Figure 4).
Finally, our results suggest that ﬂow cytometry analyses
of LIP and ROS in RBCs might reﬂect “real-time” iron
accumulation and as such might complement the measure-
ments of serum ferritin—an acute phase reactant which
is elevated in various inﬂammatory states, not necessarily
related to iron overload [33]. The LIP assay does not reﬂect
iron that has already accumulated in tissues and therefore
cannot replace liver biopsy or MRI; however, since this assay
is nonhazardous and much cheaper, when performed on
multiple occasions, it might predict potential iron overload
in tissues as well.
5.Conclusions
RBCs, retics, and developing erythroid precursors take up
iron through a Tf-independent pathway. This pathway is
operative under pathological iron-overload situation in the
presence of non-Tf iron in the serum. The incoming non-
Tf iron does not participate in heme synthesis and Hb
production, but induces ROS generation, which results in
cytotoxicity and a decrease in the erythroid cell yield.
In addition, the ﬂow cytometry methodology used in
the present study may provide an analytical platform for
practical and accurate measurements of LIP and ROS in
RBCs for evaluating iron-overload and chelation therapy.
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